Description
This study will identify important barriers to and facilitators of translating an efficacious diabetes prevention intervention (Group Lifestyle Balance, GLB) into routine clinical practice, outside of a research context.
Aims include: (1) Evaluate the clinical effectiveness of GLB, (2) Evaluate the impact of GLB on healthcare utilization, costs, and cost-effectiveness, and (3) Evaluate GLB implementation within and across Sutter Health regions and clinics.
Principal Investigator
Kristen M.J. Azar, R.N., BSN, MSN/MPH, Robert Romanelli, Ph.D., MPH
Co-Investigator(s)
Sylvia Sudat, PhD, Alice R. Pressman, Ph.D., M.S.
Funder
National Institute of Diabetes and Digestive and Kidney Diseases
Start Date
April 01, 2017
End Date
March 31, 2022
Related Studies
A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians.
Culturally Adapted DPP [Diabetes Prevention Program] Intervention for Mexican Americans in Primary Care: An RCT [randomized controlled trial]
Evaluation of Chronic Care Transformation at PAMF
Investigators: Cheryl Stults, Ph.D., Ellis C. Dillon, Ph.D.
Gestational Diabetes in Asian Americans: Predictors, Problems, and Progression
Managing Cardiometabolic Disease in Primary Care
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
New Weigh of Life Program Evaluation
Research Aimed at Improving Both Mood and Weight (RAINBOW)
Strength Training Regimen for Normal Weight Diabetics (STRONG-D) Study
The Medication Metronome Project
eCMP (electronic Cardiometabolic Program)
Investigator(s): Kristen M.J. Azar, R.N., BSN, MSN/MPH